KLSE:SUNMED Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, KLSE:SUNMED stock has a consensus rating of "Buy" and an average price target of RM 1.85. The average 1-year stock price forecast is 3.93% higher than the current stock price, while the lowest is RM 1.25 (-29.78%) and the highest is RM 2.30 (+29.21%).

Price Target: RM 1.85 (+3.93%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	RM 1.25	RM 1.85	RM 1.90	RM 2.30
Change	-29.78%	+3.93%	+6.74%	+29.21%

Analyst Ratings

The average analyst rating for KLSE:SUNMED stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	1	4	4	4
Buy	1	1	0	0
Hold	0	3	6	6
Sell	0	0	0	0
Strong Sell	1	1	1	1
Total	3	9	11	11

Financial Forecast

Revenue This Year

2.64B

from 2.20B

20.11%

from 2.20B

Revenue Next Year

3.10B

from 2.64B

17.27%

from 2.64B

EPS This Year

0.02

from 0.02

7.10%

from 0.02

EPS Next Year

0.03

from 0.02

38.44%

from 0.02

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.06B	1.46B	1.85B	2.20B	2.64B
Revenue Growth	-	36.83%	27.15%	18.78%	20.11%
Gross Profit	661.33M	900.04M	1.18B	1.38B	1.68B
Gross Margin	62.11%	61.78%	63.96%	62.87%	63.50%
Operating Income	194.57M	256.99M	327.34M	297.58M	420.65M
Net Income	209.90M	181.63M	257.50M	252.21M	281.18M
EPS	-	-	-	0.02	0.02
EPS Growth	-	-	-	-	7.10%
Forward PE	-	-	-	-	73.74
Free Cash Flow	-	-1.05B	282.30M	-268.34M	-102.20M
No. Analysts	-	-	-	-	12

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is MYR.

Revenue Forecast

Revenue	2026	2027	2028
High	2.8B
Avg	2.6B
Low	2.6B

Revenue Growth

Revenue Growth	2026	2027	2028
High	26.6%
Avg	20.1%
Low	17.1%

EPS Forecast

EPS	2026	2027	2028
High	0.03
Avg	0.02
Low	0.02

EPS Growth

EPS Growth	2026	2027	2028
High	15.4%
Avg	7.1%
Low	-11.3%